Device Trial Radar · NCT03782116
Stress Incontinence Trial With Elitone Device
Last checked: Nov 20, 2026Latest source record: Jan 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
87
Actual
Start
Sep 1, 2018
Primary completion
Mar 31, 2019
Study completion Mar 31, 2019
Sponsor
- Lead sponsor
- Elidah, Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 20, 2018
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- Female only, from 21 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized controlled study in which subjects are assigned to either a treatment group or a control (sham) group. Pre- and post-study outcome measures evaluate the change in incontinence episodes on women with mild-moderate stress urinary incontinence.
Conditions
- Stress Urinary Incontinence
Interventions
Transcutaneous electrical stimulation (Elitone)Device
Transcutaneous perineal area electrical stimulation
Primary outcomes
What the sponsor says the trial is designed to measure.
- Efficacy Assessed by Percent Reduction in Urinary Incontinence EpisodesTime frame: 12 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nationwide At-Home study
Monroe, Connecticut
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.